Announcements Trials

Browse Landscape

Clinical Trials

1 trials

Recent Start date Enrollment

Blast Crisis × carfilzomib × Plasma cell × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Multiple Myeloma 180 Recurrence 26 Neoplasms, Plasma Cell 16 Smoldering Multiple Myeloma 4 Neoplasms 4 Lymphoma 4 Leukemia, Plasma Cell 2 Leukemia 2 Disease 2 Waldenstrom Macroglobulinemia 1 Small Cell Lung Carcinoma 1 Renal Insufficiency 1 Plasmacytoma 1 Ovarian Neoplasms 1 Lymphoma, Non-Hodgkin 1 Lymphoma, Large B-Cell, Diffuse 1 Leukemia, Myeloid, Acute 1 Kidney Neoplasms 1 Kidney Failure, Chronic 1 Immunoglobulin Light-chain Amyloidosis 1 Hodgkin Disease 1 Hematologic Neoplasms 1 Graft vs Host Disease 1 Carcinoma, Non-Small-Cell Lung 1 Bone Marrow Neoplasms 1 Blast Crisis 1 Anemia 1 Amyloidosis 1

Interventions

Cyclophosphamide 34 Peripheral Blood Stem Cell Transplantation 31 fludarabine phosphate 27 Tacrolimus 24 Busulfan 24 Antilymphocyte Serum 22 Mycophenolic Acid 19 Methotrexate 17 Cyclosporine 17 Radiotherapy 14 Filgrastim 14 Whole-Body Irradiation 13 Methylprednisolone 13 Cord Blood Stem Cell Transplantation 11 Melphalan 9 Flow Cytometry 9 Etoposide 9 Therapeutics 8 Sirolimus 6 Psychiatric Rehabilitation 6 Polymerase Chain Reaction 6 Granulocyte Colony-Stimulating Factor 6 sargramostim 5 Prednisone 4 Cytarabine 4 Carboplatin 4 fludarabine 3 Thiotepa 3 Ondansetron 3 Leucovorin 3

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01204164 2016-05-06

TG02-101

Tragara Pharmaceuticals, Inc.

Phase 1 Completed

Blast Crisis, Multiple Myeloma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡